Ortizo, Rubie .

HRN: 10-43-62  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2023
AMPICILLIN 1GM (VIAL)
10/30/2023
11/06/2023
IV
2gm
Q6
Prom X 14 Hrs
Checking Final Appropriateness 
10/31/2023
CEFUROXIME 500MG (TAB)
10/31/2023
11/07/2023
PO
500mg Tab
BID
Prom X 21 Hours, Post Nsvd
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: